366 related articles for article (PubMed ID: 37525872)
1. Review and Application of Integrin Alpha v Beta 6 in the Diagnosis and Treatment of Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma.
Lian Y; Zeng S; Wen S; Zhao X; Fang C; Zeng N
Technol Cancer Res Treat; 2023; 22():15330338231189399. PubMed ID: 37525872
[TBL] [Abstract][Full Text] [Related]
2. Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium.
Ethun CG; Lopez-Aguiar AG; Pawlik TM; Poultsides G; Idrees K; Fields RC; Weber SM; Cho C; Martin RC; Scoggins CR; Shen P; Schmidt C; Hatzaras I; Bentrem D; Ahmad S; Abbott D; Kim HJ; Merchant N; Staley CA; Kooby DA; Maithel SK
J Am Coll Surg; 2017 Apr; 224(4):406-413. PubMed ID: 28017812
[TBL] [Abstract][Full Text] [Related]
3. Distal bile duct carcinomas and pancreatic ductal adenocarcinomas: postulating a common tumor entity.
Schmuck RB; de Carvalho-Fischer CV; Neumann C; Pratschke J; Bahra M
Cancer Med; 2016 Jan; 5(1):88-99. PubMed ID: 26645826
[TBL] [Abstract][Full Text] [Related]
4. Hilar cholangiocarcinoma and pancreatic ductal adenocarcinoma share similar histopathologies, immunophenotypes, and development-related molecules.
Gandou C; Harada K; Sato Y; Igarashi S; Sasaki M; Ikeda H; Nakanuma Y
Hum Pathol; 2013 May; 44(5):811-21. PubMed ID: 23134772
[TBL] [Abstract][Full Text] [Related]
5. Tumour origin, diagnostic accuracy and histopathological evaluation in patients with periampullary cancer: nationwide cohort study.
Byrling J; Ghazi S; Andersson B
BJS Open; 2023 Sep; 7(5):. PubMed ID: 37864577
[TBL] [Abstract][Full Text] [Related]
6. The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma.
Hooper JE; Morgan TK; Grompe M; Sheppard BC; Troxell ML; Corless CL; Streeter PR
Hum Pathol; 2012 Oct; 43(10):1583-9. PubMed ID: 22406361
[TBL] [Abstract][Full Text] [Related]
7. Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas.
Zaccari P; Cardinale V; Severi C; Pedica F; Carpino G; Gaudio E; Doglioni C; Petrone MC; Alvaro D; Arcidiacono PG; Capurso G
World J Gastroenterol; 2019 Aug; 25(31):4343-4359. PubMed ID: 31496617
[TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary approach to tumors of the pancreas and biliary tree.
Brown KM
Surg Clin North Am; 2009 Feb; 89(1):115-31, ix. PubMed ID: 19186234
[TBL] [Abstract][Full Text] [Related]
9. Cholangiocarcinoma.
Krasinskas AM
Surg Pathol Clin; 2018 Jun; 11(2):403-429. PubMed ID: 29751883
[TBL] [Abstract][Full Text] [Related]
10. Cholangiocarcinoma: new insights into disease pathogenesis and biology.
Braconi C; Patel T
Infect Dis Clin North Am; 2010 Dec; 24(4):871-84, vii. PubMed ID: 20937455
[TBL] [Abstract][Full Text] [Related]
11. A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma.
Collins AL; Wojcik S; Liu J; Frankel WL; Alder H; Yu L; Schmittgen TD; Croce CM; Bloomston M
Ann Surg Oncol; 2014 Jan; 21(1):133-8. PubMed ID: 24046106
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic Carcinosarcoma With Cholangiocarcinoma Elements and Prominent Bile Duct Spread.
Usui G; Hashimoto H; Kusakabe M; Shirota G; Sugiura Y; Fujita Y; Satou S; Harihara Y; Horiuchi H; Morikawa T
Int J Surg Pathol; 2019 Dec; 27(8):900-906. PubMed ID: 31203684
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma.
Lok T; Chen L; Lin F; Wang HL
Hum Pathol; 2014 Feb; 45(2):394-400. PubMed ID: 24439226
[TBL] [Abstract][Full Text] [Related]
14. [Intraductal papillary neoplasms of the bile duct (IPNB). Diagnostic criteria, carcinogenesis and differential diagnostics].
Schlitter AM; Klöppel G; Esposito I
Pathologe; 2013 Nov; 34 Suppl 2():235-40. PubMed ID: 24196621
[TBL] [Abstract][Full Text] [Related]
15. Hilar cholangiocarcinoma is pathologically similar to pancreatic duct adenocarcinoma: suggestions of similar background and development.
Nakanuma Y; Sato Y
J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):441-7. PubMed ID: 24446421
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
[TBL] [Abstract][Full Text] [Related]
17. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.
Patsenker E; Wilkens L; Banz V; Osterreicher CH; Weimann R; Eisele S; Keogh A; Stroka D; Zimmermann A; Stickel F
J Hepatol; 2010 Mar; 52(3):362-9. PubMed ID: 20137822
[TBL] [Abstract][Full Text] [Related]
18. Synchronous pancreatic adenocarcinoma and intrahepatic cholangiocarcinoma arising in the context of intraductal papillary neoplasms.
Bansal A; Thung SN; Zhu H; Schwartz M; Lewis S
Clin Imaging; 2016; 40(5):897-901. PubMed ID: 27183137
[TBL] [Abstract][Full Text] [Related]
19. Synchronous occurrence of gastrointestinal stromal tumor, pancreatic intraductal papillary mucinous neoplasm, and intrahepatic cholangiocarcinoma: Case report.
Hou Q; Zhang W; Niu J; Tian M; Liu J; Cui L; Li Y
Medicine (Baltimore); 2022 Jul; 101(28):e29460. PubMed ID: 35839023
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic ductal adenocarcinoma and distal cholangiocarcinoma: a proposal of preoperative diagnostic score for differential diagnosis.
Muttillo EM; Ciardi A; Troiano R; Saullo P; Masselli G; Guida M; Tortora A; Sperduti I; Marinello G; Chirletti P; Caronna R
World J Surg Oncol; 2021 Jan; 19(1):10. PubMed ID: 33430887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]